TM
ABOUT CLYRA
Clyra Medical Technologies, founded on our mission of “Make Lives Better”, is a healthcare company that develops and commercializes products designed to safely treat wound and skin infections and promote wound healing, while reducing the need for antibiotics.
Clyra Medical Technologies is a proud member of the BioLargo Family of Companies (www.biolargo.com).
Clyra is a subsidiary of BioLargo, Inc., a publicly traded company, with the stock symbol OTCQB:BLGO. BioLargo is a technology innovator and solutions provider focused on some of the world’s most pressing human health and environmental challenges including advanced water treatment, environmental remediation, air quality control, medical technologies, and more.
TECHNOLOGY AND PRODUCTS
Clyra's innovative copper-iodine complex technology is based on combining compounds that create a gentle but effective oxidative reaction (Learn more). This reaction is effective against a wide range of organisms that cause disease (pathogens) such as: viruses, fungi, spores and antibiotic-resistant strains of bacteria. Clyra technology is safe, effective, bio-compatible, and cost-effective for their intended use.
Clyra technology causes the instantaneous release of a powerful yet safe antimicrobial agent in measured doses when it is mixed by water from any source, including a wound exudate. Clyra has characterized this antimicrobial technology in conformance with FDA standards, and confirms that the efficacy and safety of this technology is in conformance with international standards and literature on the subject.
​
Clyra technology can be delivered in multiple formats such as: liquid, dry solution, hydrogel, or embedded in a pad. Clyra products are not associated with any known acquired microbial resistance. Clyra's products can be used by wound care centers, hospitals, nursing homes, urgent care clinics and home healthcare, in military applications, and by consumers.
STRATEGY
The wound and skin care markets are established, yet continually emerging. Technology and innovation provide opportunities for improved patient care and revenue potential. However, this growth does not come without challenges. Finding a technology that is cost effective and efficacious, and that can be incorporated into a variety of products is a difficult task.
Clyra products may solve many of the concerns that exist with current wound care and related products, and it can be potentially positioned in all segments of healthcare.
​Clyra Medical Technologies works with leaders in the wound care market, as well as in other medical and healthcare areas. Clyra technology provides competitive advantages to companies that incorporate this technology into their product line, to more importantly make a difference in patient outcomes, as well as to provide healthcare professionals safe, cost- effective green technologies.